The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, has completed its acquisition of the New York Stem Cell Foundation (NYSCF), a pioneering nonprofit dedicated to advancing cures through stem cell research. This unification creates one of the most powerful nonprofit engines for biomedical discovery, combining JAX’s expertise in genetics and mouse models with NYSCF’s advanced stem cell and automation technologies. Founded in 2005, NYSCF has pioneered the development of scalable stem cell platforms that allow scientists worldwide to study disease, discover drugs, and explore regenerative medicine.
Read the full article: The Jackson Laboratory Acquires New York Stem Cell Foundation to Transform Biomedical Research and Accelerate Precision Therapies for Patients //
Source: https://www.prnewswire.com/news-releases/the-jackson-laboratory-acquires-new-york-stem-cell-foundation-to-transform-biomedical-research-and-accelerate-precision-therapies-for-patients-302588940.html